Gofen & Glossberg’s Allstate ALL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $23.2M | Sell |
170,781
-3,416
| -2% | -$447K | 0.6% | 44 |
|
|
2022
Q3 | $21.7M | Sell |
174,197
-4,367
| -2% | -$543K | 0.61% | 42 |
|
|
2022
Q2 | $22.6M | Sell |
178,564
-1,330
| -0.7% | -$174K | 0.6% | 45 |
|
|
2022
Q1 | $24.9M | Sell |
179,894
-10,543
| -6% | -$1.32M | 0.57% | 45 |
|
|
2021
Q4 | $22.4M | Sell |
190,437
-127
| -0.1% | -$15K | 0.48% | 52 |
|
|
2021
Q3 | $24.3M | Sell |
190,564
-2,198
| -1% | -$290K | 0.57% | 43 |
|
|
2021
Q2 | $25.1M | Sell |
192,762
-2,276
| -1% | -$294K | 0.6% | 43 |
|
|
2021
Q1 | $22.4M | Buy |
195,038
+4,833
| +3% | +$533K | 0.57% | 48 |
|
|
2020
Q4 | $20.9M | Buy |
190,205
+187
| +0.1% | +$18.4K | 0.57% | 49 |
|
|
2020
Q3 | $17.9M | Sell |
190,018
-554
| -0.3% | -$51.7K | 0.55% | 49 |
|
|
2020
Q2 | $18.5M | Buy |
190,572
+2,156
| +1% | +$212K | 0.62% | 49 |
|
|
2020
Q1 | $17.3M | Buy |
188,416
+1,726
| +0.9% | +$188K | 0.68% | 44 |
|
|
2019
Q4 | $21M | Buy |
186,690
+690
| +0.4% | +$75.3K | 0.67% | 46 |
|
|
2019
Q3 | $20.2M | Sell |
186,000
-3,054
| -2% | -$319K | 0.68% | 45 |
|
|
2019
Q2 | $19.2M | Buy |
189,054
+72
| +0% | +$7.04K | 0.66% | 49 |
|
|
2019
Q1 | $17.8M | Sell |
188,982
-2,824
| -1% | -$255K | 0.63% | 51 |
|
|
2018
Q4 | $15.8M | Sell |
191,806
-3,061
| -2% | -$275K | 0.63% | 50 |
|
|
2018
Q3 | $19.2M | Buy |
194,867
+7,676
| +4% | +$749K | 0.66% | 48 |
|
|
2018
Q2 | $17.1M | Buy |
187,191
+3,055
| +2% | +$290K | 0.63% | 49 |
|
|
2018
Q1 | $17.5M | Buy |
184,136
+10,635
| +6% | +$1.03M | 0.65% | 48 |
|
|
2017
Q4 | $18.2M | Buy |
173,501
+231
| +0.1% | +$22.8K | 0.65% | 50 |
|
|
2017
Q3 | $15.9M | Sell |
173,270
-6,145
| -3% | -$559K | 0.59% | 57 |
|
|
2017
Q2 | $15.9M | Buy |
179,415
+1,787
| +1% | +$151K | 0.6% | 53 |
|
|
2017
Q1 | $14.5M | Sell |
177,628
-3,807
| -2% | -$300K | 0.57% | 59 |
|
|
2016
Q4 | $13.4M | Sell |
181,435
-555
| -0.3% | -$39.1K | 0.55% | 62 |
|
|
2016
Q3 | $12.6M | Buy |
181,990
+437
| +0.2% | +$30.1K | 0.52% | 62 |
|
|
2016
Q2 | $12.7M | Buy |
181,553
+4,159
| +2% | +$278K | 0.53% | 61 |
|
|
2016
Q1 | $12M | Buy |
177,394
+2,819
| +2% | +$177K | 0.51% | 64 |
|
|
2015
Q4 | $10.8M | Buy |
174,575
+750
| +0.4% | +$46.6K | 0.47% | 69 |
|
|
2015
Q3 | $10.1M | Buy |
173,825
+1,423
| +0.8% | +$89K | 0.46% | 70 |
|
|
2015
Q2 | $11.2M | Sell |
172,402
-402
| -0.2% | -$27.6K | 0.47% | 66 |
|
|
2015
Q1 | $12.3M | Buy |
172,804
+2,203
| +1% | +$156K | 0.53% | 57 |
|
|
2014
Q4 | $12M | Buy |
170,601
+3,593
| +2% | +$236K | 0.51% | 63 |
|
|
2014
Q3 | $10.2M | Buy |
167,008
+2,583
| +2% | +$155K | 0.45% | 67 |
|
|
2014
Q2 | $9.65M | Buy |
164,425
+16,548
| +11% | +$954K | 0.43% | 71 |
|
|
2014
Q1 | $8.02M | Buy |
147,877
+13,798
| +10% | +$740K | 0.37% | 77 |
|
|
2013
Q4 | $7.31M | Buy |
134,079
+69,500
| +108% | +$3.71M | 0.34% | 77 |
|
|
2013
Q3 | $3.26M | Buy |
64,579
+22,520
| +54% | +$1.13M | 0.17% | 115 |
|
|
2013
Q2 | $2.02M | Buy |
+42,059
| New | +$2.05M | 0.11% | 143 |
|
Other funds holding ALL
Gofen & Glossberg's ALL Position: Q4 2022 in Review
Gofen & Glossberg reduced its Allstate (ALL) stake by 2% in Q4 2022, selling an estimated $447K and leaving 170,781 shares worth $23.2M. The position accounts for 0.6% of the portfolio, ranked #44.
Gofen & Glossberg first reported a position in ALL in Q2 2013 and has held it in 39 quarters since. The position peaked at $25.1M in Q2 2021. 1,257 funds tracked by Wall St. Rank hold ALL as of Q4 2022.
- Gofen & Glossberg held 170,781 shares of Allstate worth $23.2M as of Q4 2022.
- Gofen & Glossberg sold 3,416 Allstate shares in Q4 2022, an estimated $447K.
- Allstate made up 0.6% of Gofen & Glossberg's portfolio in Q4 2022, its #44 holding.
- Gofen & Glossberg first reported a position in Allstate in Q2 2013 and has held it in 39 quarters since.
- Gofen & Glossberg's Allstate position peaked at $25.1M in Q2 2021.
- 1,257 funds tracked by Wall St. Rank held Allstate as of Q4 2022.
Based on Gofen & Glossberg's 13F filing for Q4 2022, filed 13 Jan 2023.